Pharmaids Pharmaceuticals Ltd

Dematerialisation compliance and depository update

• RTA confirms compliances completed for dematerialisation of shares for the period.
• Physical certificates dematerialised were mutilated and cancelled after verification; registered owner updated.
• Depositories updated as registered owner within 15 days of receipt of valid DRF and share certificates.
• Details of securities furnished to the stock exchanges.

Pharmaids Pharmaceuticals Limited: Trading Window closed from Oct 01, 2026 till 48 hours after the declaration of Unaudited Financial Results for the quarter and half year ended September 30, 2026.

Litigation: cheque dishonour against Anugraha Chemicals

• Filed two complaints under BNS Act Section 223 and NI Act Section 138.
• Against M/s Anugraha Chemicals and partners Sourabh S Hadimani and Sneha Hadimani.
• Claims total ₹2.625 crore; cheques 740165 (₹52.5 lakh) and 740166 (₹2.1 crore).
• Cheques dishonoured on 23 July 2026; payment stopped by drawer.
• Court: 34th Addl Chief Judicial Magistrate, Bengaluru; no liability disclosed; recovery sought.
• Disinvestment Agreement dated 10 July 2025 underpins the dispute; company seeks recovery as complainant.

AGM Details

• Date, time, and mode: 11 September 2026 at 12:00 IST via VC/OAVM.
• Cut-off date for voting: 04 September 2026; total shareholders on cut-off: 8,866.
• Attendance via VC: 1 promoter group shareholder and 83 public.

Resolutions

• Adoption of audited financial statements (standalone and consolidated) and reports thereon.
• Appointment of Ms. Mini Manikantan as Executive Director, retiring by rotation.
• Approval of material related party transactions to be entered into by the Company.
• Approval of material related party transactions to be entered into by Subsidiaries.

Voting Results

• All resolutions passed with overwhelming support.
• Adoption of financial statements approved by majority in favour.
• Executive Director appointment approved.
• Material related party transactions for the company and subsidiaries approved.

Dividend

• No dividend proposed or declared.

Director Changes

• Ms. Mini Manikantan appointed Executive Director, retiring by rotation.

Auditors

• No changes to auditors disclosed.

Material Related Party Transactions

• Company and subsidiaries approved material related party transactions; values not disclosed.

Other Material Approvals

• No other material approvals reported.

AGM Details

• Held on 11 Sep 2026, 12:00–12:36 IST, via VC/OAVM.
• 84 members attended via video conference.

Resolutions

• Adoption of standalone and consolidated financial statements for FY ending March 31, 2026.
• Reappointment of Ms Mini Manikantan as Executive Director, who retires by rotation.
• Approval of material related party transactions to be entered into by the company.
• Approval of material related party transactions to be entered into by subsidiaries.
• Resolutions deemed passed on 11 Sep 2026 subject to requisite votes in favour.

Director Changes

• Ms Mini Manikantan reappointed as Executive Director; retires by rotation.

Material Related Party Transactions

• Company-level RPTs approved; counterparty and value not disclosed.
• Subsidiary-level RPTs approved; counterparty and value not disclosed.

AGM Details

• Date/time/mode: 11 September 2026, 12:00 IST; VC/OAVM.
• Cut-off for e-voting: 4 September 2026; voting window: 8–10 September 2026.

Resolutions to Vote On

• Adoption of standalone and consolidated financial statements for FY2025-26.
• Re-appointment of Ms Mini Manikantan as Executive Director (retire by rotation).
• Approval of material related party transactions for the Company.
• Approval of material related party transactions for subsidiaries.

Dividend

• No final dividend proposed for FY2025-26.

Governance & Auditors

• Statutory Auditor: reappointed M/s PPKG & Co for five years (2023–28).
• Internal Auditor FY2025-26: TN Raghavendra; FY2026-27: M/s V Mahendra & Associates.
• Secretarial Auditor: Kashinath Sahu & Co.

Key Director/KMP Changes

• Independent Director Yogananda Moolemath appointed Jan 1, 2026.
• Mopperthy Sudheer ceased Independent Director Jan 5, 2026.
• Chairman shifted: Pattamadai Vijay appointed Chairman Dec 5, 2025; Shankarappa Vinaya Babu became Vice-Chairman.
• CEO/KMP changes: Dr. S Prasad resigned Aug 7, 2025; Sidde Gowda resigned Dec 10, 2025; Jagadeesh M N resigned Jun 25, 2026.
• Re-appointment: Ms Mini Manikantan offered for re-appointment as Executive Director.

Material Related Party Transactions

• RPT approvals cover transactions with related parties; details in Annexure I (Company) and Annexure II (Subsidiaries).
• Aggregate RPT limits: Company up to Rs 66 cr; Subsidiaries up to Rs 130 cr.

Subsidiaries / Other Governance Notes

• Anugraha Chemicals ceased to be a material subsidiary in Sept 2025.
• Siri Labvivo Diet Private Limited ceased as step-down subsidiary Mar 2026.

Board approvals

• Board approves unaudited standalone and consolidated results for quarter ended June 30, 2026.
• Limited Review Report by M/s PPKG & Co enclosed with results.
• Advertisement planned with QR code and webpage link for full results and report.
• Notice for 37th AGM to be held via VC/OAVM; details to follow.
• Board meeting duration: 04:57 PM to 06:15 PM.

Meeting Details

• Date: 12 August 2026; time and venue not disclosed.

Key Agenda Items

• Consider and approve unaudited standalone and consolidated financial results for quarter ended June 30, 2026.

Other Notes

• Trading window closed from 01 July 2026; reopens 48 hours after results declaration.
• Info regarding results will be available on the company's website.